Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

69.4K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.4K
DNA Bacteriophages01:26

DNA Bacteriophages

1.4K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Escherichia coli</i> vacuolating factor, involved in avian cellulitis, induces actin contraction and binds to cytoskeleton proteins in fibroblasts.

The journal of venomous animals and toxins including tropical diseases·2021
Same author

Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment.

Toxins·2018
Same author

Plesiomonas shigelloides exports a lethal cytotoxic-enterotoxin (LCE) by membrane vesicles.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2016
Same author

Curli fimbria: an Escherichia coli adhesin associated with human cystitis.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2016
Same author

Cytotoxic factor secreted by Escherichia coli associated with sepsis facilitates transcytosis through human umbilical vein endothelial cell monolayers.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2016
Same author

DIARRHEA OUTBREAK IN PERNAMBUCO, BRAZIL, ASSOCIATED WITH A HEAT-STABLE CYTOTOXIC ENTEROTOXIN PRODUCED BY Aeromonas caviae.

Revista do Instituto de Medicina Tropical de Sao Paulo·2015

Related Experiment Video

Updated: Mar 25, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

3.7K

Phage display and Shiga toxin neutralizers.

Robert Alvin Bernedo-Navarro1, Tomomasa Yano1

  • 1Department of Genetics, Evolution and Bioagents, University of Campinas (UNICAMP), SP, Brazil.

Toxicon : Official Journal of the International Society on Toxinology
|February 23, 2016
PubMed
Summary

Phage display technology is a powerful tool for discovering neutralizing agents against Shiga toxins, which cause serious public health threats like Hemolytic Uremic Syndrome (HUS). This review highlights peptides and nanobodies identified using this method.

Keywords:
Escherichia coliPhage displaySTECShiga toxins

More Related Videos

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

35.2K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.4K

Related Experiment Videos

Last Updated: Mar 25, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

3.7K
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

35.2K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.4K

Area of Science:

  • Biotechnology
  • Microbiology
  • Immunology

Background:

  • Shiga toxins pose a significant public health risk, as evidenced by past outbreaks and the absence of specific therapies for Shiga toxin-induced Hemolytic Uremic Syndrome (HUS).
  • Phage display technology has emerged as a crucial platform for developing antigen-specific molecules, including peptides and antibody fragments.

Purpose of the Study:

  • To provide an overview of phage display technology's application in identifying and characterizing neutralizing agents for Shiga toxins.
  • To review the current literature on the use of phage display for discovering novel anti-Shiga toxin therapies.

Main Methods:

  • Literature review of studies employing phage display for Shiga toxin research.
  • Analysis of identified peptides and VHH fragments (nanobodies) with neutralizing capabilities.

Main Results:

  • Phage display has successfully identified various peptides and VHH fragments capable of neutralizing Shiga toxins.
  • These identified molecules show potential as therapeutic agents against Shiga toxin-induced cellular damage.

Conclusions:

  • Phage display is an effective strategy for discovering novel neutralizing agents against Shiga toxins.
  • The identified peptides and nanobodies represent promising candidates for developing specific therapies for Shiga toxin-related diseases.